Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform.
Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see an unmet need and concerns around disease progression, like multiple sclerosis, hypertension,...
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, announced last week it had entered a strategic partnership with pharma giant Novartis to develop artificial intelligence tools to detect cardiovascular diseases.
The collaboration will focus on deploying AI algorithms that analyze ECGs to find left ventricular dysfunction, which can lead to heart failure, and...
Pharma giant Novartis is looking for creative, digital solutions that sustainably improve German healthcare.
The company has annouced the fifth installment of the Digital Health Award, with prize money of €60,000 in total available for winners.
The awards presentation takes place in Berlin on 24 March 2022, while the call is open for applications until 30 November 2021.
WHAT’S THE IMPACT
With the...
The Digital Medicine Society (DiMe) is teaming up with pharma giants AbbVie, Janssen Research and Development, Novartis, Pfizer and UCB to make nocturnal scratch an endpoint for atopic dermatitis.
Atopic dermatitis, also known as eczema, can lead to nighttime itches and scratching, which impact the quality of a patient's sleep. Recent studies have outlined wearable sensors’ role in helping to...
NOVARTIS BIOME UK ANNOUNCES SELECTION FOR HEALTHHUB 21
Novartis UK has announced the selected companies for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data driven health accelerator of the Francis Crick Institute, and LifeArc, the charity helping to turn science into benefits for patients.
The four selected companies are Living With, Macusoft, Mendelian and...
Berlin-based digital therapeutics company, Dopavision has announced the closing of a €12 million Series A financing round to develop its lead product for childhood myopia.
Seventure Partners led the round and was joined by Novartis Pharmaceuticals and the company's existing shareholders, Boehringer Ingelheim Venture Fund and Ababax Health.
WHY IT MATTERS
Myopia is the leading cause of correctable...
Berlin-based global health company Ada has signed more than 10 new partnerships with key players across sciences, insurance and health systems, including AXA OneHealth, Santéclair, Novartis, CUF, TAJ Digital Health and Sutter Health.
These organisations have opted for this partnership in order to improve patient experiences, leveraging Ada’s enterprise solutions to support the delivery of...
Berlin-based medical AI company Ada Health has announced the launch of a new partnership with Novartis in order to speed up the diagnosis for patients with immunological diseases and rare conditions.
The partnership will see Novartis use Ada Health’s AI-based, clinically validated, symptom assessment and care navigation solutions to help improve the identification and diagnosis of a number of...
Kaiku Health, maker of an oncology-focused platform that collected patient-reported outcomes, is teaming up with pharma giant Novartis on a new initiative to help monitor and manage melanoma.
The companies will zero in on creating a remote monitoring and support network for patients receiving a specific drug combination, known as BRAF and MEK inhibitors, that aims to treat melanoma. As part of...
Pharma giant Novartis Pharmaceuticals UK and UK provider of digital healthcare solutions, Cievert has announced a digital innovation partnership.
The collaboration will support patient care in rheumatology and dermatology by capturing patient-reported data.
The partnership was created via the Novartis BIOME, a project which encourages impactful collaboration in science tech, with a selection...
